32246-34-7

Basic information

• Product Name: 3-hydroxy-2,4-dimethoxybenzaldehyde
• Synonyms: 3-hydroxy-2,4-dimethoxybenzaldehyde;2,4-Dimethoxy-3-hydroxybenzaldehyde;Benzaldehyde,3-hydroxy-2,4-dimethoxy-
• CAS NO: 32246-34-7
• Molecular Formula: C₉H₁₀O₄
• Molecular Weight: 182.1733
• EINECS: 250-970-6
• Mol File: 32246-34-7.mol
• Article Data: 4

Chemical Properties

• Melting Point: 104-105 °C
• Boiling Point: 327 °C at 760mmHg
• Flash Point: 132.4 °C
• Appearance: /
• Density: 1.234 g/cm³
• Vapor Pressure: 0.000109mmHg at 25°C
• Refractive Index: 1.567
• PKA: 9.25±0.15(Predicted)
• CAS DataBase Reference: 3-hydroxy-2,4-dimethoxybenzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 3-hydroxy-2,4-dimethoxybenzaldehyde(32246-34-7)
• EPA Substance Registry System: 3-hydroxy-2,4-dimethoxybenzaldehyde(32246-34-7)

Safety Data

• Hazardous Substances Data: 32246-34-7(Hazardous Substances Data)

Usage

General Description

3-hydroxy-2,4-dimethoxybenzaldehyde is a chemical compound with the molecular formula C10H12O4. It is commonly used in organic synthesis and chemical research. This chemical is a white crystalline solid and is soluble in most organic solvents. It has been found to have potential pharmacological properties and has been studied for its antioxidant and anti-inflammatory effects. 3-hydroxy-2,4-dimethoxybenzaldehyde has also been investigated for its potential application in the development of new drugs and pharmaceutical products. Overall, this compound has attracted significant interest in the scientific community due to its diverse applications and potential benefits.

InChI:InChI=1/C9H10O4/c1-12-7-4-3-6(5-10)9(13-2)8(7)11/h3-5,11H,1-2H3

Upstream product

• 2103-57-3 2,3,4-trimethoxybenzaldehyde 
• 4055-69-0 2,3-dihydroxy-4-methoxybenzaldehyde 
• 74-88-4 methyl iodide 
• 91-10-1 1,3-dimethoxy-2-hydroxy-benzene 
• 2032-76-0 dichloromethyl-methyl sulfide 
• 186581-53-3 diazomethane 

Downstream Products

• 696601-69-1 1,8-dichloro-10-(2,4-dimethoxy-3-hydroxybenzylidene)-10H-anthracen-9-one 
• 20321-46-4 3-(benzyloxy)-2,4-dimethoxybenzaldehyde 
• 121985-85-1 6-benzyloxy-1-(5'-benzyloxy-2'-bromobenzyl)-5,7-dimethoxy-3,4-dihydroisoquinoline hydrochloride 
• 121949-68-6 1-(5'-benzyloxy-2'-bromobenzylidene)-6-benzyloxy-2-carbethoxy-5,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline 
• 121949-69-7 1-(2'-bromo-5'-hydroxybenzyl)-5,7-dimethoxy-6-hydroxy-3,4-dihydroisoquinoline hydrochloride 
• 121949-63-1 5-benzyloxy-N-<2-(3'-benzyloxy-2',4'-dimethoxyphenyl)ethyl>-2-bromophenylacetamide 
• 121949-67-5 1-(2'-bromo-5'-hydroxybenzylidene)-2-carbethoxy-5,7-dimethoxy-6-hydroxy-1,2,3,4-tetrahydroisoquinoline 
• 121949-62-0 3-benzyloxy-2,4-dimethoxy-β-nitrostyrene 
• 21882-90-6 2-(3-benzyloxy-2,4-dimethoxyphenyl)ethylamine 
• 50827-58-2 2-Hydroxymethyl-3,5-dimethoxy-[1,4]benzoquinone 
• 127581-53-7 1--4-(3-hydroxy-2,4-dimethoxybenzyl)piperazine 
• 28042-82-2 1,2-Bis-(3-hydroxy-2,4-dimethoxy-benzal)-azin 

Relevant articles and documents

SUBSTITUTED CHROMEN-4-ONE FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

The present invention provides novel compounds having the general formula: (I) wherein R1 to R10, Gi, G2 and m are as described herein, compositions including the impounds and methods of using the compounds for the treatment of hepatitis B.

Syntheses of phoyunbenes A-D and thunalbene for their anti-inflammatory evaluation

Simple and efficient first syntheses of phoyunbenes A-D and thunalbene have been developed using Horner- Wadsworth-Emmons reaction as a key step. Later, their anti-inflammatory effects were investigated in lipopolysaccharide-induced RAW-264.7 macrophages. The results revealed that phoyunbenes A-D and thunalbene showed weak inhibitory activities without cytotoxicity on the production of nitric oxide (NO) which is an important inflammatory mediator.